In addition, the hepatic injury biomarkers aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were significantly decreased by ExBID, suggesting beneficial effects on fatty liver disease. The gene discussed is GPT; the disease is fatty liver disease.